31/23/31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
03/23/03 GSK Nigeria calls an end to its business, to return cash RE
03/23/03 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
03/23/03 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
28/23/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
28/23/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
28/23/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
28/22/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
29/22/29 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
28/22/28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
31/22/31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
25/21/25 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
29/21/29 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 01/08/2011
General Counsel - 01/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.28Cr
+0.04%+3.34%+51.12%+101.82% 1,02800Cr
-0.09%+1.66%+55.02%+66.18% 65TCr
-0.02%+2.66%+18.91%+71.47% 47TCr
-1.22%+3.66%+36.44%+38.32% 35TCr
-0.79%+2.73%+19.03%+25.08% 27TCr
+0.58%+6.76%+11.13%+16.52% 26TCr
+1.55%+2.20%+39.81%+46.55% 21TCr
+0.79%+1.84%-28.27%-56.71% 19TCr
-0.52%+4.45%+32.12%+98.51% 19TCr
Average +0.18%+3.26%+26.15%+45.30% 40.02TCr
Weighted average by Cap. +0.23%+3.09%+35.15%+61.76%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!